# The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy

> **NCT01809756** · NA · TERMINATED · sponsor: **Amphia Hospital** · enrollment: 55 (actual)

## Conditions studied

- Small Cell Lung Cancer
- Non Small Cell Lung Cancer

## Interventions

- **OTHER:** Caphosol

## Key facts

- **NCT ID:** NCT01809756
- **Lead sponsor:** Amphia Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02-25
- **Primary completion:** 2016-06-01
- **Final completion:** 2016-06-01
- **Target enrollment:** 55 (ACTUAL)
- **Why stopped:** bad taste of Caphosol - early stop of intake by patients
- **Last updated:** 2020-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01809756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01809756, "The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01809756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*